MEDICAL DEVELOPMENTS ORDINARY (MVP) Short Interest

Name: MEDICAL DEVELOPMENTS ORDINARY (MVP) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

MEDICAL DEVELOPMENTS ORDINARY (ASX:MVP) had 0.01% of shares reported as short positions as of 5 June 2026, representing 12,373 shares. MEDICAL DEVELOPMENTS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.01%
Reported positions: 12,373
Industry: Pharmaceuticals, Biotechnology & Life Sciences
As of: 5 June 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

MVP

Medical Developments International

Pharmaceuticals, Biotechnology & Life Sciences

Medical Developments International (MVP) is a pharmaceutical company focused on developing and distributing innovative medical devices. They operate in the acute pain and respiratory illness treatment sectors, aiming to improve patient care globally. MDI partners with organizations like CSIRO to drive industry-leading product development.

pharmaceuticals

biotechnology

medical devices

pain management

Shorted

short percentage0.01%

reported shorts12.4K

shares on issue112.658M